THE DEAL, AT A GLANCE
From the announcementImunon
01Who is involvedBacked by our Phase 2 OVATION 2 Study of IMNN-001, demonstrating a 14From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedImunon raised $10M UnknownFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersIMUNON secured financing of up to $10 Million to advance a Phase 3 ovarian cancer trial for IMNN-001.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Imunon · Financing Record
Explore source-linked visual explanations for Imunon. Unsupported claims are withheld while source review continues.
Record 5408 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →